INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 19, 2005 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Dec 19, 2005 |
SVP Fin & Admin, CFO, & Treas
Trans History: 645
|
SVP Fin & Admin, CFO, & Treas | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 57,818 | -- | 57,818 |
| Dec 19, 2005 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,184 | -- | 13,184 |
| Dec 19, 2005 |
VP, Gen Counsel & Secretary
Trans History: 117
|
VP, Gen Counsel & Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 26,816 | -- | 26,816 |
| Dec 19, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 16,463 | -- | 16,463 |
| Dec 19, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 13,537 | -- | 13,537 |
| Dec 19, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
| Dec 19, 2005 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 57,818 | -- | 57,818 |
| Dec 19, 2005 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 404
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 250,000 | -- | 250,000 |
| Dec 19, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 17,182 | -- | 17,182 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.